Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905718-20-000209
Filing Date
2020-02-14
Accepted
2020-02-14 16:07:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 recropharma_13gam1dec312019.htm SC 13G/A 35517
  Complete submission text file 0000905718-20-000209.txt   36971
Mailing Address 60 EAST 42ND STREET SUITE 960 NEW YORK NY 10165
Business Address 60 EAST 42ND STREET SUITE 960 NEW YORK NY 10165 212-446-2465
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

EIN.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Subject) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88042 | Film No.: 20619569
SIC: 2834 Pharmaceutical Preparations